Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-05280586 vs Rituximab in Rheumatoid Arthritis
NCT01526057Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2012
- Primary completion
- Aug 2013
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of rituximab in rheumatoid arthritis (RA), sponsored by Pfizer. Started Mar 2012; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01526057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01526057.